Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

412

HTML

3009

Tables (1-5)

179

Sum=3600

Aug 7, 2011 (publication date) through Oct 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 7, 2011; 17(29): 3441-3447
Published online Aug 7, 2011. doi: 10.3748/wjg.v17.i29.3441

Table 5 Predictors of early rebleeding on multivariate analysis

	P value	Exp (B)	95% CI
Adjunct somatostatin use	0.374	0.527	0.128-2.164
Hypertension	0.175	2.864	0.627-13.086
Multiple antiplatelet medication	0.421	2.351	0.239-18.879
Hemoglobin < 7 g/dL	0.402	1.768	0.466-6.704
Hematemesis	0.072	3.672	0.889-15.179
Hematochezia	0.614	0.593	0.078-4.517
Complete Rockall score > 6	0.044	9.080	1.062-77.595

Citation: Choi CW, Kang DH, Kim HW, Park SB, Park KT, Kim GH, Song GA, Cho M. Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy. World J Gastroenterol 2011; 17(29): 3441-3447
URL: https://www.wjgnet.com/1007-9327/full/v17/i29/3441.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i29.3441